83 FR 39763 - HHS Approval of Entities That Certify Medical Review Officers

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 83, Issue 155 (August 10, 2018)

Page Range39763-39763
FR Document2018-17184

This notice publishes a list of the Department of Health and Human Services (HHS) approved Medical Review Officers certification entities. The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), applicable on October 1, 2017, addresses the role and qualifications of Medical Review Officers (MROs) and HHS approval of entities that certify MROs.

Federal Register, Volume 83 Issue 155 (Friday, August 10, 2018)
[Federal Register Volume 83, Number 155 (Friday, August 10, 2018)]
[Notices]
[Page 39763]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-17184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


HHS Approval of Entities That Certify Medical Review Officers

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice publishes a list of the Department of Health and 
Human Services (HHS) approved Medical Review Officers certification 
entities. The HHS Mandatory Guidelines for Federal Workplace Drug 
Testing Programs (Mandatory Guidelines), applicable on October 1, 2017, 
addresses the role and qualifications of Medical Review Officers (MROs) 
and HHS approval of entities that certify MROs.

FOR FURTHER INFORMATION CONTACT: Sean J. Belouin, Pharm.D., CAPT, 
United States Public Health Service, Senior Pharmacology and Regulatory 
Policy Advisor, Substance Abuse and Mental Health Services 
Administration, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 
20857; Telephone: (240) 276-2716; Email: [email protected].

SUPPLEMENTARY INFORMATION: Subpart M--Medical Review Officer (MRO), 
Section 13.2 of the Mandatory Guidelines, ``How are nationally 
recognized entities or subspecialty boards that certify MROs 
approved?'' states as follows: ``All nationally recognized entities or 
subspecialty boards which seek approval by the Secretary to certify 
physicians as MROs for federal workplace drug testing programs must 
submit their qualifications, a sample examination, and other necessary 
supporting examination materials (e.g., answers, previous examination 
statistics or other background examination information, if requested) 
(OMB Control No.: 0930-0158). Approval will be based on an objective 
review of qualifications that include a copy of the MRO applicant 
application form, documentation that the continuing education courses 
are accredited by a professional organization, and the delivery method 
and content of the examination. Each approved MRO certification entity 
must resubmit their qualifications for approval every two years. The 
Secretary shall publish at least every two years a notice in the 
Federal Register listing those entities and subspecialty boards that 
have been approved. This notice is also available on the internet at 
http://www.samhsa.gov/workplace/drug-testing.''
    HHS has completed its review of entities that certify MROs, in 
accordance with requests submitted by such entities to HHS.
    The HHS Secretary approves the following MRO certifying entities 
that offer MRO certification through examination:
American Association of Medical Review Officers (AAMRO), P.O. Box 
12873, Research Triangle Park, NC 27709, Phone: (919) 489-5407, Fax: 
(919) 490-1010, Email: [email protected], website: http://www.aamro.com/.
Medical Review Officer Certification Council (MROCC), 3231 S. Halsted 
St, #167, Chicago, IL 60608, Phone: (847) 631-0599, Fax: (847) 483-
1282, Email: [email protected], website: http://www.mrocc.org/.

DATES: HHS approval is effective July 31, 2018.

Alex M. Azar II,
Secretary.
[FR Doc. 2018-17184 Filed 8-9-18; 8:45 am]
 BILLING CODE 4162-20-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesHHS approval is effective July 31, 2018.
ContactSean J. Belouin, Pharm.D., CAPT, United States Public Health Service, Senior Pharmacology and Regulatory Policy Advisor, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857; Telephone: (240) 276-2716; Email: [email protected]
FR Citation83 FR 39763 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR